Reports for NALOXONE

Ingredient

NALOXONE

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
PMS-BUPRENORPHINE-NALOXONE 8MG 2MG TABLET Resolved 2019-05-09 2019-07-30 83732
PMS-BUPRENORPHINE-NALOXONE 8MG 2MG TABLET Resolved 2019-06-28 2019-07-30 88025
PMS-BUPRENORPHINE-NALOXONE 8MG 2MG TABLET Resolved 2019-10-04 2022-01-17 95445
TEVA-BUPRENORPHINE/NALOXONE 8MG 2MG TABLET Resolved 2019-09-26 2020-01-24 94896
TEVA-BUPRENORPHINE/NALOXONE 2MG 8MG TABLET Resolved 2022-12-01 2022-12-22 176824
TEVA-BUPRENORPHINE/NALOXONE 2MG 0.5MG TABLET Resolved 2019-10-03 2020-01-24 95396
TEVA-BUPRENORPHINE/NALOXONE 2MG 0.5MG TABLET Resolved 2021-05-20 2021-06-03 139725
TEVA-BUPRENORPHINE/NALOXONE 2MG 0.5MG TABLET Resolved 2021-06-03 2021-06-10 140363
TEVA-BUPRENORPHINE/NALOXONE 0.5MG 2MG TABLET Resolved 2021-08-27 2021-09-16 144704
TEVA-BUPRENORPHINE/NALOXONE 2MG 0.5MG TABLET Resolved 2022-08-18 2022-12-02 167203

Showing 11 to 20 of 23

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
MYLAN-BUPRENORPHINE/NALOXONE Discontinued 2019-09-17 2019-09-18 94044
MYLAN-BUPRENORPHINE/NALOXONE 8MG 2MG TABLET Discontinued 2019-09-17 2019-09-18 94048

Showing 1 to 2 of 2